TRENDING TOPICS AND NEWS IN HCT AND CELLULAR THERAPY

Scientists believe a tetravalent bispecific antibody (BsAb) might effectively combat graft-versus-host disease (GVHD), a common complication of allogeneic hematopoietic stem cell transplantation.

Researchers believe treatment with an antibacterial enzyme specific to Enterococcus faecalis may provide prophylaxis against acute graft-versus-host disease (aGVHD).

Although HLA-matched sibling donors (MSDs) are considered the gold standard for hematopoietic cell transplantation (HCT), evidence suggests comparable outcomes are possible with haploidential...

In a recent study led by Roswell Park Comprehensive Cancer Center, researchers have found that posttransplant cyclophosphamide (PTCy) leads to unique changes in vascular biomarkers, revealing a...

Changes in the oral microbiome may be implicated in the development of oral chronic graft-versus-host disease (cGVHD) in allogenic hematopoietic cell transplantation recipients, based on findings...

CD70 may be a promising target for preventing acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HCT) or treating it once it has developed,...